MAPK3 and cancer: However, the attenuation of ERK1/2 signaling following knockdown of CXCL5 or CXCR2 in the PC cell lines was not observed, suggesting that CXCL5/CXCR2 signaling might activate differential downstream signaling dependent in specific cancer types.